Umbilical Cord Blood-Derived Mesenchymal Stem Cells

mesenchymal stem cells · Institute of Hematology & Blood Diseases Hospital, China

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Umbilical Cord Blood-Derived Mesenchymal Stem Cells, covering 2012-03-16 to 2026-02-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of Umbilical Cord Blood-Derived Mesenchymal Stem Cells in the Treatment of Long-Term Cytopenia After CAR-T Therapy [EARLY_Phase 1]

See pricing